| Ident. | Authors (with country if any) | Title |
|---|
| 000C54 (2018) |
Brian L. Venables [États-Unis] ; Ny Sin [États-Unis] ; Alan Xiangdong Wang [États-Unis] ; Li-Qiang Sun [États-Unis] ; Yong Tu [États-Unis] ; Dennis Hernandez [États-Unis] ; Amy Sheaffer [États-Unis] ; Min Lee [États-Unis] ; Cindy Dunaj [États-Unis] ; Guangzhi Zhai [États-Unis] ; Diana Barry [États-Unis] ; Jacques Friborg [États-Unis] ; Fei Yu [États-Unis] ; Jay Knipe [États-Unis] ; Jason Sandquist [États-Unis] ; Paul Falk [États-Unis] ; Dawn Parker [États-Unis] ; Andrew C. Good [États-Unis] ; Ramkumar Rajamani [États-Unis] ; Fiona Mcphee [États-Unis] ; Nicholas A. Meanwell [États-Unis] ; Paul M. Scola [États-Unis] | P3-P4 ureas and reverse carbamates as potent HCV NS3 protease inhibitors: Effective transposition of the P4 hydrogen bond donor. |
| 001049 (2016) |
Sheng Liu [République populaire de Chine] ; Yubin Li [République populaire de Chine] ; Wanxing Wei [République populaire de Chine] ; Kuiwu Wang [République populaire de Chine] ; Lisheng Wang [République populaire de Chine] ; Jianyi Wang [République populaire de Chine] | Design, synthesis, molecular docking studies and anti-HBV activity of phenylpropanoid derivatives. |
| 001327 (2015) |
Wenxin Li [République populaire de Chine] ; Xiao Li [République populaire de Chine] ; Erik De Clercq [Belgique] ; Peng Zhan [République populaire de Chine] ; Xinyong Liu [République populaire de Chine] | Discovery of potent HIV-1 non-nucleoside reverse transcriptase inhibitors from arylthioacetanilide structural motif. |
| 001334 (2015) |
Lyudmyla G. Glushakova [États-Unis] ; Nidhi Sharma [États-Unis] ; Shuichi Hoshika [États-Unis] ; Andrea C. Bradley [États-Unis] ; Kevin M. Bradley [États-Unis] ; Zunyi Yang [États-Unis] ; Steven A. Benner [États-Unis] | Detecting respiratory viral RNA using expanded genetic alphabets and self-avoiding DNA. |
| 001364 (2015) |
Aidang Lu [République populaire de Chine] ; Ziwen Wang ; Zhenghong Zhou ; Jianxin Chen ; Qingmin Wang | Application of "hydrogen bonding interaction" in new drug development: design, synthesis, antiviral activity, and SARs of thiourea derivatives. |
| 001365 (2015) |
Aidang Lu [République populaire de Chine] ; Yuanyuan Ma [République populaire de Chine] ; Ziwen Wang [République populaire de Chine] ; Zhenghong Zhou [République populaire de Chine] ; Qingmin Wang [République populaire de Chine] | Application of "Hydrogen-Bonding Interaction" in Drug Design. Part 2: Design, Synthesis, and Structure-Activity Relationships of Thiophosphoramide Derivatives as Novel Antiviral and Antifungal Agents. |
| 001967 (2013) |
Sho Konno [Japon] ; Pillaiyar Thanigaimalai ; Takehito Yamamoto ; Kiyohiko Nakada ; Rie Kakiuchi ; Kentaro Takayama ; Yuri Yamazaki ; Fumika Yakushiji ; Kenichi Akaji ; Yoshiaki Kiso ; Yuko Kawasaki ; Shen-En Chen ; Ernesto Freire ; Yoshio Hayashi | Design and synthesis of new tripeptide-type SARS-CoV 3CL protease inhibitors containing an electrophilic arylketone moiety. |
| 002487 (2010) |
Zai Wang ; Jian-Dong Huang ; Kin-Ling Wong ; Pei-Gang Wang ; Hao-Jie Zhang ; Julian A. Tanner ; Ottavia Spiga ; Andrea Bernini ; Bo-Jian Zheng ; Neri Niccolai | On the mechanisms of bananin activity against severe acute respiratory syndrome coronavirus |
| 002491 (2010) |
Jun Liu ; Peng Wu ; Feng Gao ; Jianxun Qi ; Ai Kawana-Tachikawa ; Jing Xie ; Christopher J. Vavricka ; Aikichi Iwamoto ; Taisheng Li ; George F. Gao | Novel Immunodominant Peptide Presentation Strategy: a Featured HLA-A*2402-Restricted Cytotoxic T-Lymphocyte Epitope Stabilized by Intrachain Hydrogen Bonds from Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Protein▿ † |
| 002565 (2010) |
Yantao Chen [République populaire de Chine] ; Mingliang Wang ; Qianling Zhang ; Jianhong Liu | Construction of an implicit membrane environment for the lattice Monte Carlo simulation of transmembrane protein. |
| 002B97 (2009) |
Krongsakda Phakthanakanok [Thaïlande] ; Khanok Ratanakhanokchai ; Khin Lay Kyu ; Pornthep Sompornpisut ; Aaron Watts ; Surapong Pinitglang | A computational analysis of SARS cysteine proteinase-octapeptide substrate interaction: implication for structure and active site binding mechanism. |
| 003004 (2008) |
Gustav R Der [Danemark] ; Ole Kristensen ; Jette S. Kastrup ; S Ren Buus ; Michael Gajhede | Structure of a SARS coronavirus-derived peptide bound to the human major histocompatibility complex class I molecule HLA-B*1501. |
| 003049 (2008) |
Alex G. Taranto [Brésil] ; Paulo Carvalho ; Mitchell A. Avery | QM/QM studies for Michael reaction in coronavirus main protease (3CL Pro). |
| 003071 (2008) |
Veena Nukoolkarn [Thaïlande] ; Vannajan Sanghiran Lee ; Maturos Malaisree ; Ornjira Aruksakulwong ; Supot Hannongbua | Molecular dynamic simulations analysis of ritonavir and lopinavir as SARS-CoV 3CL(pro) inhibitors. |
| 003510 (2008) |
Yi-Ming Shao [Taïwan] ; Wen-Bin Yang [Taïwan] ; Tun-Hsun Kuo [Taïwan] ; Keng-Chang Tsai [Taïwan] ; Chun-Hung Lin [Taïwan] ; An-Suei Yang [Taïwan] ; Po-Huang Liang [Taïwan] ; Chi-Huey Wong [Taïwan, États-Unis] | Design, synthesis, and evaluation of trifluoromethyl ketones as inhibitors of SARS-CoV 3CL protease |
| 003586 (2007) |
Yi-Ming Shao [République populaire de Chine] ; Wen-Bin Yang ; Hung-Pin Peng ; Min-Feng Hsu ; Keng-Chang Tsai ; Tun-Hsun Kuo ; Andrew H-J Wang ; Po-Huang Liang ; Chun-Hung Lin ; An-Suei Yang ; Chi-Huey Wong | Structure-based design and synthesis of highly potent SARS-CoV 3CL protease inhibitors. |
| 003671 (2007) |
Kewen Zheng [République populaire de Chine] ; Guozheng Ma ; Jinming Zhou ; Min Zen ; Wenna Zhao ; Yongjun Jiang ; Qingsen Yu ; Jialiang Feng | Insight into the activity of SARS main protease: Molecular dynamics study of dimeric and monomeric form of enzyme. |
| 003784 (2007) |
Jiang Yin [Canada] ; Chunying Niu [Canada] ; Maia M. Cherney [Canada] ; Jianmin Zhang [Canada] ; Carly Huitema [Canada] ; Lindsay D. Eltis [Canada] ; John C. Vederas [Canada] ; Michael N. G. James [Canada] | A Mechanistic View of Enzyme Inhibition and Peptide Hydrolysis in the Active Site of the SARS-CoV 3C-like Peptidase |
| 003D96 (2006) |
Hao Chen [République populaire de Chine] ; Ping Wei ; Changkang Huang ; Lei Tan ; Ying Liu ; Luhua Lai | Only one protomer is active in the dimer of SARS 3C-like proteinase. |
| 003F82 (2006) |
D-Q Wei [République populaire de Chine] ; R. Zhang ; Q-S Du ; W-N Gao ; Y. Li ; H. Gao ; S-Q Wang ; X. Zhang ; A-X Li ; S. Sirois ; K-C Chou | Anti-SARS drug screening by molecular docking. |
| 004041 (2006) |
I-Lin Lu [République populaire de Chine] ; Neeraj Mahindroo [République populaire de Chine] ; Po-Huang Liang [République populaire de Chine] ; Yi-Hui Peng [République populaire de Chine] ; Chih-Jung Kuo [République populaire de Chine] ; Keng-Chang Tsai [République populaire de Chine] ; Hsing-Pang Hsieh [République populaire de Chine] ; Yu-Sheng Chao [République populaire de Chine] ; Su-Ying Wu [République populaire de Chine, Taïwan] | Structure-Based Drug Design and Structural Biology Study of Novel Nonpeptide Inhibitors of Severe Acute Respiratory Syndrome Coronavirus Main Protease |
